5 Einträge gefunden

1. Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?

   1. Bischoff, Jenny
   2. Boesecke, Christoph
   3. Ingiliz, Patrick
   4. Berger, Florian
   5. Simon, Karl-Georg
   6. Lutz, Thomas
   7. Schewe, Carl K

   2020 - Forschungsinformationssystem des UKE
2. Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era

   1. Ingiliz, Patrick
   2. Wehmeyer, Malte H
   3. Boesecke, Christoph
   4. Schulze Zur Wiesch, Julian
   5. Schewe, Knud
   6. Lutz, Thomas
   7. Baumgarten, Axel

   2020 - Forschungsinformationssystem des UKE
3. Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03)

   1. Wehmeyer, Malte H
   2. Ingiliz, Patrick
   3. Christensen, Stefan
   4. Hueppe, Dietrich
   5. Lutz, Thomas
   6. Simon, Karl Georg
   7. Schewe, Knud

   2018 - Forschungsinformationssystem des UKE
4. Effect of antiviral therapy for HCV on lipid levels

   1. Mauss, Stefan
   2. Berger, Florian
   3. Wehmeyer, Malte H
   4. Ingiliz, Patrick
   5. Hueppe, Dietrich
   6. Lutz, Thomas
   7. Simon, Karl G

   2017 - Forschungsinformationssystem des UKE
5. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

   1. Roeder, Claudia
   2. Jordan, Sabine
   3. Schulze Zur Wiesch, Julian
   4. Pfeiffer-Vornkahl, Heike
   5. Hueppe, Dietrich
   6. Mauss, Stefan
   7. Zehnter, Elmar

   2014 - Forschungsinformationssystem des UKE